The Association of Systemic Interleukin 6 and Interleukin 10 Levels with Sarcopenia in Elderly Patients with Chronic Obstructive Pulmonary Disease

References

• Cruz-Jentoft AJ, Baeyens TP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Landi F, Calvani R, Tosato M, et al. Protein intake and muscle health in old age: from biological plausibility to clinical evidence. Nutrients. 2016;8(5):295. doi:10.3390/nu8050295
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26(12):2793–2802. doi:10.1007/s00198-015-3194-y
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
   PubMed Web of Science ®Google Scholar
• Zembron-Lacny A, Dziubek W, Rogowski L, et al. Sarcopenia: monitoring, molecular mechanisms, and physical intervention. Physiol Res. 2014;63(6):683–691. doi:10.33549/physiolres.932692
   PubMed Web of Science ®Google Scholar
• Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045. doi:10.3389/fphys.2017.01045
   PubMed Web of Science ®Google Scholar
• Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526–e9. doi:10.1016/j.amjmed.2005.10.049
   Web of Science ®Google Scholar
• Frasca D, Blomberg BB. Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology. 2016;17(1):7–19. doi:10.1007/s10522-015-9578-8
   PubMed Web of Science ®Google Scholar
• Custodero C, Mankowski RT, Lee SA, et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: a systematic review and meta-analysis. Ageing Res Rev. 2018;46:42–59. doi:10.1016/j.arr.2018.05.004
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Robison P, Sussan TE, Chen H, et al. Impaired calcium signaling in muscle fibers from intercostal and foot skeletal muscle in a cigarette smoke-induced mouse model of COPD. Muscle Nerve. 2016;56(2):282. doi:10.1002/mus.25466
   Web of Science ®Google Scholar
• Bin Y, Xiao Y, Huang D, et al. Theophylline inhibits cigarette smoke-induced inflammation in skeletal muscle by upregulating HDAC2 expression and decreasing NF-kappaB activation. Am J Physiol Lung Cell Mol Physiol. 2019;316(1):L197–L205. doi:10.1152/ajplung.00005.2018
   PubMed Web of Science ®Google Scholar
• Girón R, Matesanz C, García-Río F, et al. Nutritional state during COPD exacerbation: clinical and prognostic implications. Ann Nutr Metab. 2009;54(1):52–58. doi:10.1159/000205960
   PubMed Web of Science ®Google Scholar
• Hallin R, Koivisto-Hursti UK, Lindberg E, Janson C. Nutritional status, dietary energy intake and the risk of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2006;100(3):561–567. doi:10.1016/j.rmed.2005.05.020
   PubMed Web of Science ®Google Scholar
• Smith SH. Using albumin and prealbumin to assess nutritional status. Nursing. 2017;47(4):65–66. doi:10.1097/01.NURSE.0000511805.83334.df
   PubMedGoogle Scholar
• Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580. doi:10.1136/thx.2003.019588
   PubMed Web of Science ®Google Scholar
• Natsui K, Tanaka K, Suda M, et al. High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int. 2006;17(1):105–108. doi:10.1007/s00198-005-1923-3
   PubMed Web of Science ®Google Scholar
• Bodine SC, Furlow JD. Glucocorticoids and skeletal muscle. Adv Exp Med Biol. 2015;872:145–176. doi:10.1007/978-1-4939-2895-8_7
   PubMed Web of Science ®Google Scholar
• Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian working group for sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101. doi:10.1016/j.jamda.2013.11.025
   PubMed Web of Science ®Google Scholar
• Said EA, Al-Reesi I, Al-Shizawi N, et al. Defining IL-6 levels in healthy individuals: a meta-analysis. J Med Virol. 2021;93(6):3915–3924. doi:10.1002/jmv.26654
   PubMed Web of Science ®Google Scholar
• Foreman MG, Zhang L, Murphy J, et al.; COPDGene Investigators. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD gene study. Am J Respir Crit Care Med. 2011;184(4):414–420. doi:10.1164/rccm.201011-1928OC
   PubMed Web of Science ®Google Scholar
• Kirchengast S, Huber J. Gender and age differences in lean soft tissue mass and sarcopenia among healthy elderly. Anthropol Anz. 2009;67(2):139–151. doi:10.1127/0003-5548/2009/0018
   PubMed Web of Science ®Google Scholar
• Vitenberga Z, Pilmane M, Babjoniseva A. The evaluation of inflammatory, anti-inflammatory and regulatory factors contributing to the pathogenesis of COPD in airways. Pathol Res Pract. 2019;215(1):97–105. doi:10.1016/j.prp.2018.10.029
   PubMed Web of Science ®Google Scholar
• Lane N, Robins RA, Corne J, et al. Regulation in chronic obstructive pulmonary disease: the role of regulatory T-cells and Th17 cells. Clin Sci. 2010;119(2):75–86. doi:10.1042/CS20100033
   PubMed Web of Science ®Google Scholar
• Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669-675. doi:10.2147/COPD.S130790
   Google Scholar
• Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88(4):1379–1406. doi:10.1152/physrev.90100.2007
   PubMed Web of Science ®Google Scholar
• Fischer CP. Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev. 2006;12:6–33.
   PubMed Web of Science ®Google Scholar
• Serrano AL, Baeza-Raja B, Perdiguero E, Jardí M, Muñoz-Cánoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7(1):33–44. doi:10.1016/j.cmet.2007.11.011
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Schmidt-Arras D, et al. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813(5):878–888. doi:10.1016/j.bbamcr.2011.01.034
   PubMed Web of Science ®Google Scholar
• Xia Z, Cholewa J, Zhao Y, et al. Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal intervention. Front Physiol. 2017;8:434. doi:10.3389/fphys.2017.00434
   PubMed Web of Science ®Google Scholar
• Santilli F, Lapenna D, Barba SL, et al. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus. Free Radic Biol Med. 2015;80:101–110. doi:10.1016/j.freeradbiomed.2014.12.010
   PubMed Web of Science ®Google Scholar
• Haddad F, Zaldivar F, Cooper DM, et al. IL-6-induced skeletal muscle atrophy. J Appl Physiol. 2005;98(3):911–917. doi:10.1152/japplphysiol.01026.2004
   PubMed Web of Science ®Google Scholar
• Rennick D, Davidson N, Berg D. Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol. 1995;76(2):174–178. doi:10.1016/S0090-1229(95)90144-2
   Google Scholar
• Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–181. doi:10.1038/nri2711
   PubMed Web of Science ®Google Scholar
• Sandri M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol. 2013;45(10):2121-2129. doi:10.1016/j.biocel.2013.04.023
   Google Scholar
• Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab. 2003;88(3):1055–1058. doi:10.1210/jc.2002-021437
   PubMed Web of Science ®Google Scholar
• Clasen BF, Poulsen MM, Carlos E, et al. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment. J Clin Endocrinol Metab. 2014;99(12):2565–2573. doi:10.1210/jc.2014-2215
   Web of Science ®Google Scholar
• Silva B, Lira FS, Ramos D, et al. Severity of COPD and its relationship with IL-10. Cytokine. 2018;106:95–100. doi:10.1016/j.cyto.2017.10.018
   PubMed Web of Science ®Google Scholar
• Martinez M, Arnalich F, Hernanz A. Alterations of anorectic cytokine levels from plasma and cerebrospinal fluid in idiopathic senile anorexia. Mech Ageing Dev. 1993;72(2):145–153. doi:10.1016/0047-6374(93)90096-A
   PubMed Web of Science ®Google Scholar
• Morley JE. Anorexia of ageing: a key component in the pathogenesis of both sarcopenia and cachexia. J Cachexia Sarcopenia Muscle. 2017;8(4):523–526. doi:10.1002/jcsm.12192
   PubMed Web of Science ®Google Scholar
• Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14(12):877–882. doi:10.1016/j.jamda.2013.05.009
   PubMed Web of Science ®Google Scholar